Insider Selling: Itron (NASDAQ:ITRI) SVP Sells $10,117.16 in Stock

Itron, Inc. (NASDAQ:ITRIGet Free Report) SVP Laurie Ann Pulatie-Hahn sold 124 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $81.59, for a total value of $10,117.16. Following the completion of the sale, the senior vice president directly owned 32,650 shares of the company’s stock, valued at $2,663,913.50. The trade was a 0.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Laurie Ann Pulatie-Hahn also recently made the following trade(s):

  • On Friday, February 20th, Laurie Ann Pulatie-Hahn sold 729 shares of Itron stock. The shares were sold at an average price of $100.17, for a total value of $73,023.93.
  • On Thursday, February 19th, Laurie Ann Pulatie-Hahn sold 3,755 shares of Itron stock. The stock was sold at an average price of $99.54, for a total value of $373,772.70.
  • On Wednesday, February 11th, Laurie Ann Pulatie-Hahn sold 142 shares of Itron stock. The shares were sold at an average price of $105.26, for a total transaction of $14,946.92.

Itron Stock Performance

ITRI opened at $81.53 on Friday. The company has a market cap of $3.62 billion, a price-to-earnings ratio of 13.00, a PEG ratio of 0.72 and a beta of 1.35. The company’s fifty day moving average price is $89.88 and its two-hundred day moving average price is $96.12. Itron, Inc. has a 1-year low of $78.53 and a 1-year high of $142.00. The company has a current ratio of 2.66, a quick ratio of 2.24 and a debt-to-equity ratio of 0.97.

Itron (NASDAQ:ITRIGet Free Report) last posted its earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.23. The company had revenue of $586.98 million for the quarter, compared to analyst estimates of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. The firm’s revenue was down 3.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.52 EPS. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. On average, analysts expect that Itron, Inc. will post 6.01 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Needham & Company LLC began coverage on shares of Itron in a report on Friday, March 6th. They set a “buy” rating and a $124.00 price objective on the stock. Roth Mkm reaffirmed a “buy” rating and issued a $136.00 price objective on shares of Itron in a research report on Wednesday, April 29th. JPMorgan Chase & Co. dropped their target price on shares of Itron from $133.00 to $113.00 and set an “overweight” rating on the stock in a research report on Thursday, April 16th. TD Cowen reduced their target price on Itron from $145.00 to $130.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Finally, Raymond James Financial started coverage on Itron in a report on Tuesday, April 21st. They set an “underperform” rating on the stock. Eight equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $131.22.

Read Our Latest Report on Itron

Institutional Trading of Itron

Several institutional investors and hedge funds have recently bought and sold shares of the company. Entropy Technologies LP grew its position in Itron by 6.3% in the first quarter. Entropy Technologies LP now owns 8,278 shares of the scientific and technical instruments company’s stock worth $742,000 after acquiring an additional 490 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Itron by 10.1% in the 1st quarter. Renaissance Technologies LLC now owns 461,761 shares of the scientific and technical instruments company’s stock worth $41,388,000 after purchasing an additional 42,300 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of Itron by 12.2% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 673,420 shares of the scientific and technical instruments company’s stock valued at $60,359,000 after purchasing an additional 73,020 shares during the last quarter. Caxton Associates LLP purchased a new position in shares of Itron during the 1st quarter valued at about $2,212,000. Finally, Systematic Financial Management LP lifted its position in Itron by 75.2% in the 1st quarter. Systematic Financial Management LP now owns 194,099 shares of the scientific and technical instruments company’s stock worth $17,397,000 after buying an additional 83,301 shares during the last quarter. 96.19% of the stock is currently owned by hedge funds and other institutional investors.

Itron Company Profile

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

See Also

Insider Buying and Selling by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.